Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells.

Diabetes & metabolism journal

Velasquez C, Vasquez JS, Balcazar N.
PMID: 28868828
Diabetes Metab J. 2017 Aug;41(4):303-315. doi: 10.4093/dmj.2017.41.4.303.

BACKGROUND: The increase in circulating free fatty acid (FFA) levels is a major factor that induces malfunction in pancreatic β-cells. We evaluated the effect of FFAs reconstituted according to the profile of circulating fatty acids found in obese adolescents...

Cite
Velasquez C, Vasquez JS, Balcazar N. In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells. Diabetes Metab J. 2017;41(4):303-315doi: 10.4093/dmj.2017.41.4.303.
Velasquez, C., Vasquez, J. S., & Balcazar, N. (2017). In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells. Diabetes & metabolism journal, 41(4), 303-315. https://doi.org/10.4093/dmj.2017.41.4.303
Velasquez, Claudia, et al. "In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells." Diabetes & metabolism journal vol. 41,4 (2017): 303-315. doi: https://doi.org/10.4093/dmj.2017.41.4.303
Velasquez C, Vasquez JS, Balcazar N. In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells. Diabetes Metab J. 2017 Aug;41(4):303-315. doi: 10.4093/dmj.2017.41.4.303. PMID: 28868828; PMCID: PMC5583408.
Copy Download .nbib Format: NLM
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus.

Diabetes & metabolism journal

Hwang YC, Jun JE, Jeong IK, Ahn KJ, Chung HY.
PMID: 30688048
Diabetes Metab J. 2019 Oct;43(5):582-589. doi: 10.4093/dmj.2018.0124. Epub 2019 Jan 16.

BACKGROUND: The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective effects over statin monotherapy.METHODS: This was a single-center, randomized,...

Cite
Hwang YC, Jun JE, Jeong IK, et al. Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J. 2019;43(5):582-589doi: 10.4093/dmj.2018.0124.
Hwang, Y. C., Jun, J. E., Jeong, I. K., Ahn, K. J., & Chung, H. Y. (2019). Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus. Diabetes & metabolism journal, 43(5), 582-589. https://doi.org/10.4093/dmj.2018.0124
Hwang, You Cheol, et al. "Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus." Diabetes & metabolism journal vol. 43,5 (2019): 582-589. doi: https://doi.org/10.4093/dmj.2018.0124
Hwang YC, Jun JE, Jeong IK, Ahn KJ, Chung HY. Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J. 2019 Oct;43(5):582-589. doi: 10.4093/dmj.2018.0124. Epub 2019 Jan 16. PMID: 30688048; PMCID: PMC6834829.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries